Walgreens CEO isn't convinced Amazon will get into healthcare

Business Insider-8 hours ago

Walgreens Boots Alliance CEO Stefano Pessina doesn't see Amazon getting into the pharmacy business. His comments come at a time when other healthcare companies have been taking Amazon's potential entry into healthcare very seriously. Pessina said if Amazon were to get into the pharmacy business, it would have ...

Express Scripts CEO sees Amazon as a potential pharmacy partner

CNBC-10 hours ago

Express Scripts CEO Tim Wentworth welcomes Amazon's consideration to make a push into the multibillion-dollar pharmacy market. He also cautions that lowering consumer prices is not "the magic" of selling prescriptions online. Wentworth would not confirm whether Express Scripts is talking with Amazon about a ...

Express Scripts CEO says open to insurer deal, ties with Amazon
Chicago Tribune-6 hours ago

Express Scripts CEO sees Amazon as possible partner
St. Louis Business Journal-3 hours ago

Express Scripts CEO sees Amazon as a potential partner: CNBC
Reuters-11 hours ago

Express Scripts CEO says he sees Amazon as a potential partner
Nasdaq-11 hours ago

Statement from FDA Commissioner Scott Gottlieb, M.D., on the approval of a new formulation of buprenorphine and FDA’s efforts to promote more widespread innovation and access to opioid addiction treatments
With the approval today of a monthly formulation of the drug buprenorphine for the treatment of opioid use disorder, patients have access to a new and longer-acting option for the treatment of opioid addiction. Millions of Americans are suffering from addiction to opioid drugs, and millions more are worried that the overdose epidemic could claim the lives of a friend or loved one. We need immediate actions to help those suffering from an opioid use disorder transition to lives of sobriety. Continue reading.

Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for oral testimony before the House Committee on Energy and Commerce Hearing, “Implementing the 21st Century Cures Act: An Update from FDA and NIH”

	Chairman Burgess, Ranking Member Greene, members of the subcommittee: Thank you for the opportunity to testify today on the anniversary of the 21st Century Cures Act, and to update you onFDA’s progress in implementing the provisions of this landmark legislation.  The Cures Act gave FDA a broad new set of authorities and resources to adapt our policies and organizational structure, to make sure that our efforts are as modern as the transformative medical products that we’re seeing. Continue reading.

• German regulators OK corrective plan for a Dr. Reddy’s formulation plant